CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
2.510
-0.090 (-3.46%)
At close: Apr 24, 2024, 4:00 PM
2.590
+0.080 (3.19%)
After-hours: Apr 24, 2024, 7:48 PM EDT

CureVac Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20222021202020192018
Market Capitalization
5621,1476,41814,306--
Market Cap Growth
--82.12%-55.14%---
Enterprise Value
1076605,52312,75753-70
PE Ratio
-4.75-4.33-13.72-90.85--
PS Ratio
12.3216.0054.84240.03--
PB Ratio
0.872.028.2016.49--
P/FCF Ratio
-4.32-2.88-6.5924.13--
P/OCF Ratio
-5.26-3.77-7.7022.46--
EV/Sales Ratio
2.349.2047.19214.052.70-4.70
EV/EBITDA Ratio
-3.65-2.80-12.58-107.76-0.510.90
EV/EBIT Ratio
-3.43-2.53-12.09-97.09-0.480.85
EV/FCF Ratio
-3.04-1.66-5.6721.52-0.480.73
Debt / Equity Ratio
0.070.080.040.08-1.850.00
Debt / EBITDA Ratio
-0.15-0.19-0.07-0.57-0.860.00
Debt / FCF Ratio
-0.13-0.11-0.030.11-0.810.00
Quick Ratio
3.173.242.335.361.702.35
Current Ratio
3.563.742.635.612.042.60
Asset Turnover
0.050.070.080.060.14-
Interest Coverage
-39.57-66.21-38.90-4.87-67.58-257.66
Return on Equity (ROE)
-48.40%-40.60%-58.80%-38.60%1863.50%-
Return on Assets (ROA)
-33.80%-26.80%-30.80%-15.70%-77.90%-
Return on Capital (ROIC)
-47.75%-43.36%-57.47%-14.32%-273.75%-226.44%
Earnings Yield
-57.23%-23.09%-7.29%-1.10%--
FCF Yield
-63.26%-34.69%-15.18%4.14%--
Buyback Yield / Dilution
-19.43%-1.73%-6.00%---
Total Shareholder Return
-19.43%-1.73%-6.00%---
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).